LBO — GRANDVIEW MEDICAL CENTER
IRR: 15.8% | MOIC: 2.08x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
15.8%
IRR
2.08x
MOIC
$897.7M
Entry EV
$1.3B
Exit EV
$461.9M
Equity Invested
Sources & Uses
S&UTotal · $897.7M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $348.6M | 38.8% | |
| Sub Debt | $87.2M | 9.7% | |
| Equity | $461.9M | 51.5% | |
| Enterprise Value | $871.6M | 97.1% | |
| Transaction Fees | $26.1M | 2.9% | |
| Total Uses | $897.7M | 100.0% |
Interpretation
INTAt 2.08x MOIC and 15.8% IRR over 5 years, this deal meets the 15-20% range — acceptable with operational upside.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $124.8M |
| Exit Ev | $1.3B |
| Net Debt At Exit | $348.7M |
| Equity At Exit | $961.3M |
| Equity Invested | $461.9M |
| Total Value Created | $499.4M |
| Value From Growth | $394.8M |
| Value From Multiple | $43.6M |
| Value From Deleveraging | $87.1M |